53 related articles for article (PubMed ID: 11585553)
1. Tumor necrosis factor gene polymorphisms in patients with sporadic Parkinson's disease.
Nishimura M; Mizuta I; Mizuta E; Yamasaki S; Ohta M; Kaji R; Kuno S
Neurosci Lett; 2001 Sep; 311(1):1-4. PubMed ID: 11585553
[TBL] [Abstract][Full Text] [Related]
2. Anti-Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease.
Peter I; Dubinsky M; Bressman S; Park A; Lu C; Chen N; Wang A
JAMA Neurol; 2018 Aug; 75(8):939-946. PubMed ID: 29710331
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies.
Nalls MA; Blauwendraat C; Vallerga CL; Heilbron K; Bandres-Ciga S; Chang D; Tan M; Kia DA; Noyce AJ; Xue A; Bras J; Young E; von Coelln R; Simón-Sánchez J; Schulte C; Sharma M; Krohn L; Pihlstrøm L; Siitonen A; Iwaki H; Leonard H; Faghri F; Gibbs JR; Hernandez DG; Scholz SW; Botia JA; Martinez M; Corvol JC; Lesage S; Jankovic J; Shulman LM; Sutherland M; Tienari P; Majamaa K; Toft M; Andreassen OA; Bangale T; Brice A; Yang J; Gan-Or Z; Gasser T; Heutink P; Shulman JM; Wood NW; Hinds DA; Hardy JA; Morris HR; Gratten J; Visscher PM; Graham RR; Singleton AB; ; ;
Lancet Neurol; 2019 Dec; 18(12):1091-1102. PubMed ID: 31701892
[TBL] [Abstract][Full Text] [Related]
4. Inflammation, Dopaminergic Brain and Bilirubin.
Jayanti S; Dalla Verde C; Tiribelli C; Gazzin S
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511235
[TBL] [Abstract][Full Text] [Related]
5. Quantitative and causal analysis for inflammatory genes and the risk of Parkinson's disease.
Yi M; Li J; Jian S; Li B; Huang Z; Shu L; Zhang Y
Front Immunol; 2023; 14():1119315. PubMed ID: 36926335
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of α-Synuclein in Parkinson's Disease: From a Neuron-Glia Crosstalk Perspective.
Yi S; Wang L; Wang H; Ho MS; Zhang S
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499080
[TBL] [Abstract][Full Text] [Related]
7. Association Between Rheumatoid Arthritis and Risk of Parkinson's Disease: A Meta-Analysis and Systematic Review.
Li D; Hong X; Chen T
Front Neurol; 2022; 13():885179. PubMed ID: 35645965
[TBL] [Abstract][Full Text] [Related]
8. Inflammation and immune dysfunction in Parkinson disease.
Tansey MG; Wallings RL; Houser MC; Herrick MK; Keating CE; Joers V
Nat Rev Immunol; 2022 Nov; 22(11):657-673. PubMed ID: 35246670
[TBL] [Abstract][Full Text] [Related]
9. Transcriptome Analysis of Induced Pluripotent Stem Cells and Neuronal Progenitor Cells, Derived from Discordant Monozygotic Twins with Parkinson's Disease.
Vlasov IN; Alieva AK; Novosadova EV; Arsenyeva EL; Rosinskaya AV; Partevian SA; Grivennikov IA; Shadrina MI
Cells; 2021 Dec; 10(12):. PubMed ID: 34943986
[TBL] [Abstract][Full Text] [Related]
10. Translation Imaging in Parkinson's Disease: Focus on Neuroinflammation.
Belloli S; Morari M; Murtaj V; Valtorta S; Moresco RM; Gilardi MC
Front Aging Neurosci; 2020; 12():152. PubMed ID: 32581765
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial Signatures in Circulating Extracellular Vesicles of Older Adults with Parkinson's Disease: Results from the EXosomes in PArkiNson's Disease (EXPAND) Study.
Picca A; Guerra F; Calvani R; Marini F; Biancolillo A; Landi G; Beli R; Landi F; Bernabei R; Bentivoglio AR; Monaco MRL; Bucci C; Marzetti E
J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32059608
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of miR-4492 and IL-10 is involved in chronic rhinosinusitis with nasal polyps.
Li L; Feng J; Zhang D; Yong J; Wang Y; Yao J; Huang R
Exp Ther Med; 2019 Nov; 18(5):3968-3976. PubMed ID: 31611936
[TBL] [Abstract][Full Text] [Related]
13. Vinpocetine regulates levels of circulating TLRs in Parkinson's disease patients.
Ping Z; Xiaomu W; Xufang X; Liang S
Neurol Sci; 2019 Jan; 40(1):113-120. PubMed ID: 30315378
[TBL] [Abstract][Full Text] [Related]
14. Human pluripotent stem cell derived midbrain PITX3(eGFP/w) neurons: a versatile tool for pharmacological screening and neurodegenerative modeling.
Watmuff B; Hartley BJ; Hunt CP; Fabb SA; Pouton CW; Haynes JM
Front Cell Neurosci; 2015; 9():104. PubMed ID: 25873861
[TBL] [Abstract][Full Text] [Related]
15. Role of α-synuclein in inducing innate and adaptive immunity in Parkinson disease.
Allen Reish HE; Standaert DG
J Parkinsons Dis; 2015; 5(1):1-19. PubMed ID: 25588354
[TBL] [Abstract][Full Text] [Related]
16. Association of
Dai D; Lin P; Wang Y; Zhou X; Tao J; Jiang D; Zhou H; Ru P; Pan G; Li J; Zhang Y; Yin H; Duan S
Biomed Rep; 2014 Sep; 2(5):713-718. PubMed ID: 25054016
[TBL] [Abstract][Full Text] [Related]
17. The role of inflammation in sporadic and familial Parkinson's disease.
Deleidi M; Gasser T
Cell Mol Life Sci; 2013 Nov; 70(22):4259-73. PubMed ID: 23665870
[TBL] [Abstract][Full Text] [Related]
18. Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity.
Sanchez-Guajardo V; Barnum CJ; Tansey MG; Romero-Ramos M
ASN Neuro; 2013 Apr; 5(2):113-39. PubMed ID: 23506036
[TBL] [Abstract][Full Text] [Related]
19. Genetic determinants of neuronal vulnerability to apoptosis.
Almeida A
Cell Mol Life Sci; 2013 Jan; 70(1):71-88. PubMed ID: 22695677
[TBL] [Abstract][Full Text] [Related]
20. Neuroinflammation and non-motor symptoms: the dark passenger of Parkinson's disease?
Barnum CJ; Tansey MG
Curr Neurol Neurosci Rep; 2012 Aug; 12(4):350-8. PubMed ID: 22580742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
